Podcasts about Methicillin

Man Says He Visited Heaven, Met Jesus During Near-Death Experience Watch this video at- https://youtu.be/3FQmcCFZ8Ng?si=x4U0Eezqh21CuDDg CBN News 2.28M subscribers 123,685 views May 16, 2024 Randy Kay's "afterlife" experience still leaves him visibly emotional as he recounts details of visiting heaven, meeting Jesus, and returning to share his harrowing journey. Kay, author of the book, "Heaven Stormed: A Heavenly Encounter Reveals Your Assignment in the End Time Outpouring and Tribulation," told CBN News he was once a denier of near-death experience claims — until he faced his own purported heaven journey. He recalled his own afterlife experience, which began with a sore calf. At first, he thought he had strained a muscle, but while working out and going on a bike ride, his calf began to swell. "I was able to make it back home and then went to the doctor to get an anti-inflammatory prescription, and lo and behold, when I pressed my heel into the floor as the doctor had suggested, I collapsed," Kay said. "And I was rushed to the emergency room." It turns out, the pain and swelling were due to seven blood clots that had formed. He then contracted Methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacteria. "The doctor said I was a walking dead man," Kay said. "And then the septic shock which entered into my body caused a traffic jam in my vessels, my vascular system." The chaos landed Kay in a dire situation — one that he believes sent him to heaven. "Everything went dark initially and the next moment of recall, I was looking down on my body," he said. "I was being pulled by this light. I know that sounds cliche, almost, but it's absolutely true." Kay continued, "I was in a kind of very vague, ethereal space initially where I saw these figures in front of me, and they were warring against each other. There's no other way of putting it." After his return from his after-death experience, Kay discerned he was watching spiritual warfare play out. Regardless of what people choose to believe, Kay's physical body was dead at this point, making these memories and claims quite fascinating. "My heart had stopped," he said, noting that hospital records indicate he was clinically dead for 30 minutes and 49 seconds. During that time, Kay believes he was experiencing heaven, noting he was aware that her was himself but suddenly was seeing and visualizing the world quite differently. "I was seeing things, hearing things beyond which I would be able to do otherwise in my body," he said.

In this episode of the ICHE Podcast, we delve into the topic of Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA), focusing on healthcare-associated infections and transmission. Our expert panel of authors from recently published ICHE papers includes Anthony Harris, MD, MPH, Elise Martin, MD, MS, and Philip M. Polgreen, MD, MPH. Listen as they discuss the prevalence of these infections, the risks they pose, and the strategies that can be employed to reduce transmission in both healthcare settings and households. At the conclusion of today's episode, each participant offers a practical, actionable recommendation for listeners.

HEALTH NEWS   An apple cider vinegar drink a day? New study shows it might help weight loss Food Additive in Pizza, Pancakes Linked to Lower Sperm Counts Ramadan fasting may protect patients with heart problems, say researchers An investigation into the potential association between nutrition and Alzheimer's disease Breakthrough Discovery Shows That Resonant Frequencies Can Kill Cancer Cells Study finds interactions with dogs can increase brainwaves associated with stress relief and heightened concentration     An apple cider vinegar drink a day? New study shows it might help weight loss Holy Spirit University of Kaslik (Lebanon), March 13, 2024   An experimental study, released today, looks into whether apple cider vinegar could be effective for weight loss, reduce blood glucose levels and reduce blood lipids (cholesterol and triglycerides). A double-blinded, randomized, clinical trial in a group of overweight and obese young people aged from 12–25 years suggest it could reduce all three—but it might not be as simple as downing an apple cider vinegar drink a day. The participants were instructed to consume either 5, 10 or 15ml of apple cider vinegar diluted into 250ml of water each morning before they ate anything for 12 weeks. A control group consumed an inactive drink (a placebo) made (from lactic acid added to water) to look and taste the same. After a period of three months apple cider vinegar consumption was linked with significant falls in body weight and body mass index (BMI). On average, those who drank apple cider vinegar during that period lost 6–8kg in weight and reduced their BMI by 2.7–3 points, depending on the dose. They also showed significant decreases in the waist and hip circumference. The authors also report significant decreases in levels of blood glucose, triglycerides, and cholesterol in the apple cider groups. While the study appears promising, there are also reasons for caution. The study participants were aged from 12 to 25, so we can't say whether the results could apply to everyone.   Food Additive in Pizza, Pancakes Linked to Lower Sperm Counts University of Kentucky, March 11, 2024 An ingredient commonly found in many baked goods and processed foods — including school lunches — may cause oxidative stress, DNA damage and decreased testosterone levels and sperm counts in male mammals. Sodium aluminum phosphate is an additive used in food products as an emulsifying agent, leavening acid and stabilizer. It is a white, odorless solid slightly soluble in water. The widespread use of sodium aluminum phosphate in everyday food products and commercially baked goods such as cakes, muffins and biscuits, and self-rising flours and baking powders. It is also used in processed cheeses to improve texture and melting properties. A peer-reviewed scientific literature on aluminum reproductive toxicity by Robert A. Yokel, Ph.D., published in Critical Reviews in Toxicology found aluminum exposure can lead to adverse reproductive outcomes in male and female mammals. Yokel's analysis revealed that “male reproductive endpoints were significantly affected after exposure to lower levels of Al [aluminum] than females.” In both male and female mice and rats, increased aluminum intake resulted in higher concentrations of the metal in the fetus, placenta and testes.   Ramadan fasting may protect patients with heart problems, say researchers University of Sharjah (United Arab Emirates) & University of Utah, March 13, 2024 Those observing Ramadan may have their cholesterol, other lipids, and inflammatory markers in their blood reduced. This is the conclusion of a group of scientists examining the model of Ramadan Intermittent Fasting (RIF) in overweight and obese people. "RIF is associated with improvements in plasma sphingosine, sphinganine sphingomyelin, and dihydrosphingomyelin lipid species," the scientists write in their study published in Scientific Reports. RIF is a special type of intermittent fasting during which fasting Muslims refrain from eating, drinking (including water), smoking, or engaging in sexual activities from pre-dawn to sunset. The fasting duration differs depending on geographical location, but it is generally estimated to last between 12-17 hours a day. The daily average fasting duration for Muslims worldwide is reported to be approximately 15 hours per day, depending on location.   An investigation into the potential association between nutrition and Alzheimer's disease Capital Medical University (China) (Frontiers) Malnutrition is the most common nutritional issue in Alzheimer's disease (AD) patients, but there is still a lack of a comprehensive evaluation of the nutritional status in AD patients. This study aimed to determine the potential association of various nutritional indices with AD at different stages. Lower levels of total protein, albumin, globulin, and apolipoprotein A1 were associated with AD (all p 

Things Your Vet Wished You Worried About More Animal Radio Veterinary Correspondent Dr. Marty Becker has a list of things he wishes his clients would pay more attention to than they do. He'll also tell you what you unnecessarily worry too much about. Listen Now Healthiest Breeds Pet Breeds compiled a list of 33 dog breeds that either have a clean health record, or are associated with only one, two or three health problems at most. And, the top seven have NO major or minor health concerns at all. They are…(drum roll please). Listen Now How To Pick A Pet Food Lucy Pet Foundation's Doc Halligan has what you need to know in order to pick the best food for your pet and your budget. Just because it's expensive doesn't mean it's good. You'll learn how to read the label. Listen Now Pets May Be Breeding Ground For MRSA Research suggests family pets might actually be reservoirs for Methicillin-resistant Staphylococcus aureus, or MRSA. Researchers believe pets might be an important factor behind the increase of MRSA outbreaks. Listen Now Pets Destroy Eight Million Electronic Devices A study says American pets have bitten, chewed or damaged at least 8-million electronic devices! All that damage caused an estimated $3 billion in repair and replacement costs! Researchers found 1/3rd of the damaged devices were smart-phones; 2/3rds of the incidents happened when the pet was not being supervised. And interestingly, male pets are 50% more likely than female pets to damage electronic devices. Listen Now Read more about this week's show.

 1:19 Labiotech.eu news2:32 Biomedical Research & Bio-Products12:15 Model N21:39 Institute of Clinical MedicineThis week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in Norway; Kyle Forcier, senior director of life sciences product marketing at Model N; and Dr. Andreas Roetzer, head of R&D for vaccines at Biomedical Research & Bio-Products.The next breakthrough in cancer treatment?In our body, we have an innate immune system and an immune system that is developed throughout life. Part of the innate immune system consists of so-called NK (natural killer) cells. This is a type of immune cell that specializes in killing cancer cells. These cells may be of great importance for cancer treatment in the future. NK cells kill cancer cells with the help of small “killer torpedoes,” or vesicles, that the NK cells secrete. Vesicles are small bubbles with a fatty wall of lipids and a space filled with toxic proteins. Researchers at the Institute of Clinical Medicine in Norway have recently discovered new things about these killer vesicles.“We have discovered that we can separate the killer torpedoes from other types of vesicles so that they form a kind of arsenal of weapons. Our research also shows that this type of vesicle is probably stored in a separate room inside the NK cell,” Miriam Aarsund Larsen said.Model N publishes revenue reportModel N, Inc. recently announced the results of its fifth annual State of Revenue Report. The report captures detailed data intended to help life sciences and high-tech industry executives grappling with how to grow company revenue and market share. Most executives named inflation as a significant headwind, with 84% calling it the single biggest impact on innovation.“Our findings show three main themes: Innovation collides with current market realities, innovation directly impacts revenue management, and the use of technology for revenue management is expanding,” said Suresh Kannan, chief product officer, Model N. “As organizations continue to navigate the current economic climate, the quality and reliability of technology solutions are more important than ever. These insights help us understand how to empower our customers to create and bring life-changing products to market.”Phase 2 study of breakthrough vaccine against toxic shock syndrome successfully completedThe first vaccine to potentially prevent Staphylococcal-induced toxic shock syndrome (TSS) has successfully completed a phase 2 study. TSS is a life-threatening condition caused by toxins that can lead to multiple organ failure and death.Nosocomial pathogen Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to widely used antibiotics. Infections with MRSA are harder to treat and therapies are more expensive as the length of hospital stays is significantly prolonged. If the treatment does not lead to rapid clearance of the bacterial pathogen, dangerous symptoms such as septic or toxic shock can occur – a potentially life-threatening condition.Researchers at Biomedical Research & Bio-Products AG, under the direction of Martha Eibl, in cooperation with MedUni Vienna's Department of Clinical Pharmacology, conducted the study. The promising results showed the TSST-1 vaccine is safe and effective, with immunization lasting for at least two years. 

On episode #18 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 12/9/22 – 12/21/22. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode Human Rabies in Texas, 2021 (CDC) Human rabies despite post-exposure prophylaxis (The Lancet) The Qatar FIFA World Cup 2022 and camel pageant championships increase risk of MERS-CoV transmission and global spread (The Lancet) An update on eukaryotic viruses revived from ancient permafrost (bioRx) Colistin monotherapy vs combination therapy for carbapenem-resistant organisms (NEJM) Outcomes of Ceftriaxone vs antistaphylococcal Penicillins or Cefazolin for definitive therapy of Methicillin-susceptible Staphylococcus aureus bacteremia (OFID) Salmonella enteritidis cardiovascular implantable electronic device infection (OFID) Evaluation of serotonin syndrome with Linezolid and serotonergic agents at an academic medical center (OFID) Preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for Intra-abdominal infections (CID) Risk factors and outcomes of invasive aspergillosis in kidney transplant recipients (CID) Predictive performance of gram staining of catheter tips for Candida catheter-related bloodstream infections (OFID) Integrative genetic manipulation of Plasmodium cynomolgireveals multidrug resistance-(JID) Clinical characteristics of patients with calcified parenchymal neurocysticercosis and perilesional edema (OFID) Impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa (CID) Factors contributing to delayed academic advancement of women in infectious diseases (OFID) Characterization of problematic alcohol use among physicians (JAMA) Alpha-gal syndrome in the ID clinic (OFID) Efficacy and safety of Azithromycin vs placebo to treat lower respiratory tract infections associated with low procalcitonin (The Lancet) Music is by Ronald Jenkees

Join our Emergency General Surgery team as they discuss Necrotizing Soft-Tissue Infections. Hosted by Drs. Jordan Nantais, Ashlie Nadler, Stephanie Mason and Graham Skelhorne-Gross. Necrotizing Soft-Tissue Infections: - Also known as “flesh eating disease”, gas gangrene, necrotizing fasciitis/myositis, Fournier's gangrene.  - Early findings are non-specific - Rapidly fatal - diagnostic delay can lead to tremendous additional morbidity and mortality Classification: - Type 1 - polymicrobial category (most common) found in immunosuppressed or elderly - Type 2 - monomicrobial infection [Group A Streptococcus > Methicillin-resistant Staphylococcus aureus (MRSA)] - Type 3 - monomicrobial infection (Vibrio or Clostridium) - Type 4 - fungal (rare) in immunocompromised or after penetration or trauma from candida or Zygomycetes. Initial Workup - History: (comorbidities, immunosuppression, recent infections or trauma) - Exam: swelling, open lesions, drainage, erythema, crepitus, and pain out of proportion      - Most common: swelling, pain, erythema      - Bullae, skin necrosis, crepitus are less common - Labs: Hb, wbc, Na, Creat, glucose, and CRP - Imaging: CT, MRI *sensitive and specific but may not change management - Cut-down: bedside vs in OR - Gm stain  Management - Initially: two large bore IVs, foley catheter, aggressive fluid resuscitation, broad spectrum antibiotics, vasopressors PRN - Abx choices: carbopenem or piperacllin-tazobactam or cefotaxime plus metronidazole. Clindamycin (antitoxin effect) and vancomycin (MRSA) should be considered. - OR: must debride all dead/infected tissue, involve other surgical specialties as needed      - Mark edge of cellulitis and use as initial debridement      - Healthy dermis – pearly and white      - Healthy fat – pale, yellow, glistening      - Healthy fascia – should bleed, doesn't easily separate from muscle      - Healthy muscle – contract with cautery      - Dressing: betadine-soaked gauze on the wound      - Most patients will need at least 3 ORs (second OR generally 8-12 hours after the first)      - No VAC or stoma at first OR References:  1.    Pelletier J, Gottlieb M, Long B, Perkins JC Jr. Necrotizing Soft Tissue Infections (NSTI): Pearls and Pitfalls for the Emergency Clinician. J Emerg Med. 2022 Apr;62(4):480-491. doi: 10.1016/j.jemermed.2021.12.012. Epub 2022 Jan 31.  2.    Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009 Feb;208(2):279-88.  3.    Edlich RF, Cross CL, Dahlstrom JJ, Long WB 3rd. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med. 2010 Aug;39(2):261-5 4.    Hoesl V, Kempa S, Prantl L, Ochsenbauer K, Hoesl J, Kehrer A, Bosselmann T. The LRINEC Score-An Indicator for the Course and Prognosis of Necrotizing Fasciitis? J Clin Med. 2022 Jun 22;11(13):3583 5.    Bulger EM, May A, Bernard A, Cohn S, Evans DC, Henry S, Quick J, Kobayashi L, Foster K, Duane TM, Sawyer RG, Kellum JA, Maung A, Maislin G, Smith DD, Segalovich I, Dankner W, Shirvan A. Impact and Progression of Organ Dysfunction in Patients with Necrotizing Soft Tissue Infections: A Multicenter Study. Surg Infect (Larchmt). 2015 Dec;16(6):694-701. 6.    LRINEC Score from: https://www.mdcalc.com/calc/1734/lrinec-score-necrotizing-soft-tissue-infection#:~:text=Patients%20were%20classified%20into%20three,%25%20and%20NPV%20of%2096%25. Retrieved July 2022. If you liked this episode, check out our recent episode titled, "Journal Review in Colorectal Surgery: Timing of Biologics and Surgery in the Setting of Crohn's Disease" which can be found here. Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Methicillin-resistant S. aureus (MRSA) is found in the community and in healthcare systems. According to the WHO, hospitalized patients with MRSA infections are 64% more likely to die than people with drug-sensitive infections. It can be difficult to treat. In this episode, hear from a patient who battled an infection for years, a infectious disease clinician who shares his daily challenges, and a researcher who using an unique approach to find the next antibiotic. Learn more about our guests this episode: Vanessa Carter: https://vanessacarter.co.za/ Andrew Morris: https://trp.utoronto.ca/person/andrew-morris Jo Handelsman: https://wid.wisc.edu/people/jo-handelsman/ This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC). Theme music Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs

In Season 2 of Superbugs and You, we continue to focus on the threat of antimicrobial resistance, which occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antibiotics and other medicines. In other words, they become “Superbugs”. This season, we will focus on Methicillin-resistant Staphylococcus aureus, Clostridioides difficile infections, resistant Neisseria gonorrhoeae, and the impact of antimicrobial resistance on modern medicine. Each episode will feature discussions with patients, physicians, and scientists to find out what's causing antimicrobial resistance, how it affects the lives of ordinary people, and most importantly, what we can do to stop it. Subscribe for new episodes beginning on October 20th! This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition. Visit the CIDRAP Antimicrobial Stewardship Project website: https://www.cidrap.umn.edu/asp Visit the Antimicrobial Resistance Fighter Coalition website: https://antimicrobialresistancefighters.org/ Theme music Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs

Welcome to PICU Doc On Call, a podcast dedicated to current and aspiring intensivists. My name is Pradip Kamat and my name is Rahul Damania and we come to you from Children's Healthcare of Atlanta Emory University School of Medicine. Today's episode is dedicated to the rational use of antibiotics in the PICU We are delighted to be joined by two brilliant Pediatric clinical pharmacists Ms Whitney Moore and Ms. Stephanie Yasechko from Children's Healthcare of Atlanta. I will turn it over to Rahul to start with our patient case... Case An 8-year-old female (24 kg, 130 cm) with PMH significant for severe persistent asthma and history of multiple PICU admissions presents to the ED with swelling, redness and inability to bear weight in her (L) lower leg. Patient had just finished soccer practice the evening prior to her ED visit when she first noticed swelling and redness of her left lower leg. She also had a fever as well as some non-bloody, non-bilious emesis. Her past h/o is significant for poorly controlled asthma with multiple admissions to the PICU. Upon arrival to the ED, patient's BP was hypotensive, tachycardic, and tachypneic. She was given two 20 mL/kg NS boluses, and blood cultures were drawn in addition to a CBC, BMP, and UA. Labs were notable for an elevated white count, lactate, and serum Cr. Patient was given a dose of antibiotic, and transported to the PICU for further workup and management. Whitney and Stephanie welcome to PICU Doc on call. Thanks Rahul and Pradip for having us. Neither one of us have any financial disclosures or conflicts of interest. We want to divide today's discussion into 3 segments- antibiotic selection, transition into dosing and end with therapeutic monitoring Whitney, what are some of the factors to consider prior to choosing an antibiotic regimen in our patient case with a preliminary diagnosis of cellulitis of the left lower extremity with possible sepsis? Whitney: First and foremost you want to consider your host so really diving deep into the patient's past medical history and secondly we should consider the likely pathogens that are causing the patient's infection. In this case given the invasive nature of her infection and recent hospital admissions I would start Vancomycin and Cefepime. Once blood cultures results are back, we can then tailor or narrow her antibiotics based on susceptibilities. Stephanie what are some of the other factors to consider prior to starting antibiotics in this patient? Other things to consider include her multiple previous hospitalizations, significant exposure to broad-spectrum antibiotics, whether or not she is immunocompromised, the presence of chronic conditions like lung disease, ventilator/trach dependency, and if patient was a resident of a long term care facility. Additionally any history of organ or bone marrow transplant or malignancy with use of chemotherapy/radiation, and/or a history of growth of multiple drug resistant organisms. This is an important point - infectious disease is not just about the relevant pathogen or "bug" but it is also about understanding the host status! Stephanie -why vancomycin and cefepime in this case? In this patient the major pathogens to consider include: P. aeruginosa (give her multiple previous PICU admissions). Also she has extensive cellulitis which necessitates antibiotic coverage against Methicillin resistant staph aureus (MRSA) and Streptococcus pyogenes . So our options in this case include vancomycin for broad-spectrum gram positive coverage, and generally either piperacillin/tazobactam or cefepime for broad-spectrum gram negative and pseudomonal coverage. As you can see by patient's Scr, it appears that she is presenting in AKI since we have no history of her having any type of renal impairment at baseline; therefore, to minimize additional AKI risk, cefepime would be our most appropriate choice for the time being. There is literature that shows us that the combination of...

Methicillin resistant staph has become a scary aspect of veterinary dermatology. It is important to know how to recognize MRSP through clinical lesions and history, collect diagnostics like cytology and C/S and be diligent about treatment. But, almost more importantly, how to recheck these cases appropriately and work up the underlying cause.Today, I am joined by Dr. Meghan Solc, DVM, Dip ACVD from Dermatology for Animals in Akron, Ohio to discuss this in-depth and important topic. Dr. Solc mentioned an excellent resource for pet owners regarding MRSP at wormsandgermsblog.com done with the Canadian Academy of Veterinary Dermatology (link below).https://www.wormsandgermsblog.com/2021/03/articles/animals/dogs/new-mrsp-methicillin-resistant-staphylococcus-pseudintermedius-fact-sheets-for-pet-owners-english-francais/

SHR # 2693:: Silent MRSA Carriers Have Twice the Mortality Rate - Dr. Arch Mainous, Ph.D. - 2percent of the US population has MRSA at any given time. That's a large portion of the population. MRSA - or Methicillin-resistant Staphylococcus aureus - is rampant in hospitals, nursing homes, gyms, prisons and anywhere there is a concentration of people with open wounds and compromised immune systems. My bet is everyone knows someone who has it. In the elderly and infants it can be deadly. When it gets into the bloodstream it travels to every organ in the body. As the name implies, it's antibiotic resistant so depending on how bad the infection is difficult to get rid of. But over time you can get rid of it. An emerging problem however is people who carry the bacteria and don't know it. If you don't develop symptoms and the infection you my never know you have it. And that will put you at greater risk of premature death.

SHR # 2693:: Silent MRSA Carriers Have Twice the Mortality Rate - Dr. Arch Mainous, Ph.D. - 2percent of the US population has MRSA at any given time. That's a large portion of the population. MRSA - or Methicillin-resistant Staphylococcus aureus - is rampant in hospitals, nursing homes, gyms, prisons and anywhere there is a concentration of people with open wounds and compromised immune systems. My bet is everyone knows someone who has it. In the elderly and infants it can be deadly. When it gets into the bloodstream it travels to every organ in the body. As the name implies, it's antibiotic resistant so depending on how bad the infection is difficult to get rid of. But over time you can get rid of it. An emerging problem however is people who carry the bacteria and don't know it. If you don't develop symptoms and the infection you my never know you have it. And that will put you at greater risk of premature death.

Hospital infections are definitely a serious, significant problem especially in the elderly and aging population communities. According to a study done by the National Institute of Health, the risk of developing a healthcare-associated infection increases with age. Join Steven Heisler on the newest episode of The Injured Senior Podcast as he shares the 14 ways to reduce your chance of getting hospital infection. Ask the hospital staff to clean their hands before treating you and ask visitors to do the same.Before your doctor uses a stethoscope on you, ask them to wipe the diaphragm with alcohol.If you are required to have a central line catheter, ask your doctor about the benefits of a central line catheter that is antibiotic-impregnated or silver chlorohexidine-coated to reduce infection.If you need surgery, choose a doctor with a low infection rate.Three to five days before your surgery, shower or bathe daily with chlorhexidine soap.Ask your doctor to have you tested for Methicillin-resistant Staphylococcus aureus or MRSA.Stop smoking long before you have surgery.On the day of surgery, remind your doctor that you may need an antibiotic one hour before the first incision.Ask your doctor to keep you warm during the surgery.Do not shave the surgical site.Avoid touching your mouth and do not set food or utensils on furniture or bedsheets.Ask your doctor to monitor your glucose levels.Avoid a urinary tract catheter if possible.If you must have an IV, make sure that it's inserted and removed under clean and sanitary conditions and changed every three to four hours.The 14 tips are courtesy of the Committee To Reduce Infection Deaths: www.hospitalinfection.orgTo find out more about the National Injured Senior Law Center or to set up a free consultation, go to https://www.injuredseniorhotline.com/ or call 855-622-6530CONNECT WITH STEVE H. HEISLER:Website: www.injuredseniorhotline.comFacebook: https://www.facebook.com/attorneysteveheisler/LinkedIn: https://www.linkedin.com/company/the-law-offices-of-steven-h.-heisler/about/Email: info@injuredseniorhotline.com

It is a period of bacterial war. A curious scientist, returning from a summer trip, has won his first victory against S. aureus. His blue green mold, secreting an unknown substance with the ability kill bacterial microbes, has forced the bacteria to retreat. Pursued into the 21st century, the bacteria have developed the power to resist Flemming's green blue mold and potentially bring a period of uncertainty to humanity. Sources: Bellis, M. 2019. The history of penicillin and antibiotics. ThoughtCo. Available from: https://www.thoughtco.com/history-of-penicillin-1992304 Biography.com. Alexander Flemming. 2019. Available from: https://www.biography.com/scientist/alexander-fleming The Centers for Disease Control and Prevention. 2019. Biggest Threats: 2019 AR Threats Report. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html Flemming, A. 1945. Penicillin Nobel Lecture. Goff, D. 2016. Antibiotics “just-in-case”.TEDx Talks; Available from: https://www.youtube.com/watch?v=ALryAB_AYiA Harkins, C. 2017. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol; 18(130)Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517843/ Lax, E. 2004.The Mold in Dr. Florey's Coat. New York (NY): Holt Paperbacks. Lima, R. Sá Del Fiol, F., Balcão, V.M. 2019. Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria. Front Pharmacol; 10(692) Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598392/ Pietzsch, J. Enhancing X-ray vision. The Nobel Prize; Available from: https://www.nobelprize.org/prizes/chemistry/1964/perspectives/ Solensky, R. 2019. Patient education: Allergy to penicillin and related antibiotics (beyond the basics). UpToDate. Available from: https://www.uptodate.com/contents/allergy-to-penicillin-and-related-antibiotics-beyond-the-basics Sprenger, M. 2015. How to stop antibiotic resistance? Here's a WHO prescription. The World Health Organization. Available from: https://www.who.int/mediacentre/commentaries/stop-antibiotic-resistance/en/ The World Health Organization. 2020. Lack of new antibiotics threatens global efforts to contain drug-resistant infections. Available from: https://www.who.int/news-room/detail/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections Wu, K. What causes antibiotic resistance? TED ED; Available from: https://ed.ted.com/lessons/how-antibiotics-become-resistant-over-time-kevin-wu Yocun, R.R., Rasmussen, J.R., Strominger, J.L. 1980. The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase. J Biol Chem; 255(9): 3977-86. Available from: https://www.ncbi.nlm.nih.gov/pubmed/7372662

Dr. Eleftherios Mylonakis, the Charles C.J. Carpenter Professor of Infectious Disease and Professor of Medicine at The Warren Alpert Medical School of Brown University as well as Professor of Molecular Microbiology and Immunology at Brown, delivers an in-depth overview discussing microbial pathogenesis and host responses. Dr. Mylonakis is an infectious disease specialist who has brought his wealth of experience to multiple hospitals in the New England area, including Massachusetts General Hospital and Miriam Hospital. Dr. Mylonakis earned his medical degree from University of Athens and has been practicing medicine for over 20 years. Dr. Mylonakis discusses his extensive work in infectious diseases and drug discovery. He explains the types of diseases, and their research in resistant bacteria, with special attention given to Methicillin-resistant Staphylococcus aureus (MRSA), which refers to a group of Gram-positive bacteria that are distinct, genetically, from other types/strains of Staphylococcus aureus. And MRSA, unfortunately, is resistant to numerous antibiotics. The research doctor discusses this particular bacteria, where it lives, and how it functions. As he states, our skin works as an effective barrier from this bacteria entering our bloodstream, but a scratch on the skin, and trauma from an accident, etc. can help the bacteria penetrate and then it can possibly spread through the bloodstream. Dr. Mylonakis explains how to identify virulence factors, and he expounds upon the current research regarding the microbiome, and how disruption could lead to colonization. Resistance traits are an important part of the research, and it is crucial to study the relationships. The noted doctor talks in detail about diagnostics, and the time we wait for cultures, to understand what is going on. Most labs wait up to 5 days, which creates a difficult situation because time is of the essence in order to effectively treat toxicity and infection. Wrapping up, Dr. Mylonakis explains the process to treat infections after diagnostics. In this podcast: How to identify virulence factors What types of bacteria are resistant to antibiotics An explanation of microbial pathogenesis

We've gotten pretty graphic on this podcast before, but this episode takes it to a whole new level. The omnipresent Staphylococcus aureus is a bacterium that wears many faces. Often that face is harmless, but Staph has the power to invade and infect nearly every organ of the body, leaving destruction (and a lot of pus) in its wake. While Staphylococcus aureus has been wreaking havoc on humans since well before the discovery of antibiotics, Methicillin-resistant Staph aureus (MRSA) has risen to terrifying prominence as resistance becomes the new norm. If any disease could make you run out (or stay in) and wash your hands, it’s this one. As always, you can find all of our sources at thispodcastwillkillyou.com/episodes. 

Prevent the spread of infectious disease in your child's sports program.Sports activities are great for your child. They’re helpful for promoting fitness, socialization, and learning a new skill. However, there is potential for the spread of infectious disease via shared equipment.Fight colds and flu with Hydralyte. Rapid and complete hydration, suitable for all ages and doctor recommended. Use code “hydrakid” to save 30% - sponsor Common diseases spread in athletics include Methicillin-resistant Staphyloccus aureus (MRSA),  Group A Streptococcus, herpes simplex virus, ringworm, athlete’s food, scabies, chicken pox, measles, mumps, and lice. Speak with your child’s sports trainer. Be sure he is aware of the most common infections related to a particular sport. Examining students before participation is an inexpensive preventative measure. Ask about sanitization of equipment. The cost of improper hygiene is greater than diligence. Encourage your children to have good personal hygiene. Shower after playing. Keep good hand washing habits. Avoid sharing clothing and water bottles. Launder sports clothes regularly. Wipe off mats and gym equipment after using. The pre-participation physical for sports should include a thorough history of prior infections and current lesions. Pediatricians can discuss risks for disease through sports participation. Your child’s vaccinations should be current. Listen as Dr. Dele Davies and Dr. Mary Anne Jackson join Melanie Cole, MS, to share how to keep your child safe from infectious disease while participating in sports.Sponsor: Fight colds and flu with Hydralyte. Rapid and complete hydration, suitable for all ages and doctor recommended. Use code “hydrakid” to save 30%

During the 1980s and 1990s, patients contracting infections in hospital, that antibiotics could no longer treat, dominated the headlines. The strict hygienic regimes, so beloved by matrons since the Nightingale era, had been undermined by a reliance on antibiotics. When one bacterium became resistant to an antibiotic, there was always another to fall back on. But when patients became infected with a bacterium which had become resistant to Methicillin, a crucial antibiotic in the health service's armoury, the defence against the bugs began to crumble. Methicillin-Resistant Staphylococcus Aureus, or MRSA, thrived in NHS hospitals and began to spread, largely unchecked, from patient to patient. As the numbers of patients contracting MRSA spiralled, the cleanliness of NHS hospitals, and their poor infection control, came under close scrutiny. Clostridium Difficile also emerged, alongside MRSA, as a source of public anxiety. It was time for the NHS to clean up its act and tackle the spread of antibiotic resistance head-on, with the infection control nurse leading the fight. Producer: Beth Eastwood.

082 | Discoveries: contending with the superbugs  Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s happening on the Canadian biotech scene. This week there have been some novel research discoveries that McMaster University, The University of Alberta, The University of British Columbia, The University of Waterloo and The University of Manitoba have been pumping out that I would like to share with you. So, keep listening and find out what exciting stories are happening from coast to coast!   +++++  Researchers from McMaster University have pinpointed a gene that is the culprit for neurological disorders, including autism.  They found that modifications of the gene thousand and one amino-acid kinase 2, aka TAOK2, has a direct link to these disorders. This gene encodes a serine/threonine protein kinase that is involved in many different processes, including, cell signaling, microtubule organization and stability, and apoptosis. This is the first comprehensive study that supports previous research suggesting the involvement of this gene and is published in Molecular Psychiatry.  According to Karun Singh, study co-author and researcher with McMaster’s Stem Cell and Cancer Research Institute, “Our studies reveal that in complex brain disorders that have a loss of many genes, a single deleted gene is sufficient to cause symptoms for the patients. This is exciting because it focuses our research effort on the individual gene, saving time and money as it will speed up the development of targeted therapeutics to this gene alone.”  Many neurodevelopmental disorders are caused by large missing pieces of genetic material in a person’s genome that contain several genes, termed a ‘microdeletion’. Accurately diagnosing a gene microdeletion helps doctors to predict patient outcome and to determine if a new treatment is available.  The researchers used genetically engineered models and computer algorithms to study a human genome, which allowed them to pinpoint the single gene in question.  The next step will be to screen candidate drugs that correct the cognitive brain deficits cause by genetic mutations in TAOK2, and identify candidates for pilot clinical trials.  The paper complements a study led by Singh on gene microdeletion published in American Journal of Human Genetics in early February.  The research was led by Singh in collaboration with Stephen Scherer from the Hospital for Sick Children. Additional researchers came from McMaster University, the Hospital for Sick Children, University of Toronto, the University Medical Center Hamburg-Eppendorf in Germany, Assiut University in Egypt and the University of Helsinki in Finland.  +++++  There was a time when the thought of growing a human body part in a lab would have been outrageous. These days, those once incredulous thoughts have become a reality.  Now, the researchers from the University of Alberta have found a way to grow human nose cartilage that will be safer and more accessible to use for facial reconstruction surgeons and will mean fewer surgeries and less pain for patients.  The team conducting the research project used a clinically approved collagen biomaterial as a scaffold to grow new cartilage that they can harvest and shape for patients who need nasal reconstruction.  The vision is that the surgeon would simply take a small biopsy of cartilage from inside the nose and provide it to the lab. The lab would then manufacture the cartilage for the surgeon in the appropriate shape and size. Once it has finished growing, the surgeon would then take that cartilage and insert it into the patient’s nose at the time of the operation.  Nasal reconstruction is a relatively common surgical outcome resulting from skin cancer. In 2015, there were more than three million cases of skin cancer in North America alone. About one-third of cases occur on a patient’s nose, with treatment options often leading to loss of function and disfigurement.  This typically ends up being a very traumatic event for the patient and comes with a high pathological cost. They really can’t hide these defects – they are very obvious. Often these patients will not interact socially because they are embarrassed by their appearance. So, the ability to help reconstruct a patient’s nose is really important.  With the assistance of six cartilage donors, the researchers harvested the cartilage cells – known as nasal chondrocytes – and multiplied them in a lab. They then seeded the cells in a scaffold to grow new tissue in a bioreactor. It takes roughly six weeks to grow enough cartilage for nasal reconstruction.  This engineered cartilage minimizes other risks and is deemed to be a superior method than that of the cartilage harvesting from the rib or ear. Cartilage taken from the rib carries a greater chance of infection, potentially collapsing the lung and an unnecessary surgery that will take the patient a longer to recuperate. Rib cartilage can also undergo warping after nasal reconstruction surgery, meaning it may not maintain the shape the surgeon wants it to. Cartilage taken from the ear is also challenging in that it can become brittle and difficult for the surgeon to manipulate. Engineered cartilage eliminates those deficiencies and could potentially supply unlimited quantities for surgeons. The University of Alberta team says it can also be custom-made for the patient.  An associate professor of surgery at the University of Alberta describes it as kind of like when you go to the tailor to get your suit made. They measure the patient based on the digital scans, and then basically just populate the cells.  The researchers have yet to test their high-quality engineered nasal cartilage in human patients. They hope that within the next two years they can begin clinical trials to prove the efficacy of the cartilage in the operating room.  +++++    Recent research conducted by the University of British Columbia (UBC)and BC Cancer denotes that precancerous lesions in the mouths of non-smokers are more likely to evolve into cancer than smokers.  Even though smoking unequivocally is related to mouth cancers, UBC dentistry PhD candidate Leigha Rock found that precancerous lesions in non-smokers are more than twice as likely to progress to cancer at an even faster rate than a smoking-associated counterpart. The study was published in Oral Oncology.  This is the first published study where the main focus was to examine the difference in risk of progression to oral cancer between non-smokers and smokers with oral precancerous lesions. While other studies have also reported a higher rate of transformation among non-smokers, this study looked at multiple risk factors including genetic markers.  Rock and colleagues looked at the case history of 445 patients with oral epithelial dysplasia (OED), a type of precancerous oral lesion, enrolled in the B.C. Oral Cancer Prediction Longitudinal study. One-third of the patients were non-smokers.  Amongst the researchers’ findings were that lesions on the floor of the mouth in non-smokers were 38 times more likely to progress to cancer than in smokers. This study is the first to report a quicker progression to cancer in non-smokers indicated at three-year and five-year rates of progression, and at 7 and 6.5 per cent higher than smokers, respectively.  The researchers suggest that the main difference in outcomes is due to a variance in the root causes of the lesions. In smokers, the oral epithelial dysplasia OED is likely the result of environmental factors. Whereas, in non-smokers, genetic susceptibility or mutations are likely to blame.  The findings show that molecular genomic markers can identify high-risk lesions, regardless of risky habits like smoking, and should be an important consideration in patient management.  The study’s results also stress the importance of taking oral lesions seriously, especially when they occur in non-smokers: “If you see a lesion in a smoker, be worried. If you see a lesion in a non-smoker, be very worried. Don’t assume it can’t be cancer because they’re a non-smoker; research indicates non-smokers may be at higher risk.”  This research was funded by the BC Cancer Foundation, the National Institutes of Health, and the National Institute of Dental and Craniofacial Research.  +++++  And some very exciting news, especially in this age of antimicrobial resistance, scientists from the University of Waterloo and the University of Manitoba have developed a new therapy to combat deadly bacteria that infects patients worldwide.  The new therapy is a biocide that targets an antibiotic-defiant bacterium such as Methicillin-resistant strafill cock us  are e us  (Staphylococcus aureus) (MRSA) to combat superbugs.  Professors at the University of Waterloo wanted to be able to help vulnerable patients suffering from chronic infections. Because once a patient is infected with a resistant strain of bacteria it is very difficult to get them well again.  This latest development provides hope in an age where bacteria are becoming resistant to antibiotics faster than researchers can develop new ones. The World Health Organization estimates 700,000 people die annually from antibiotic-resistant infections and they expect this toll to climb to 10 million by 2050, higher than the current death rate from cancer and even motor accidents combined.   University of Manitoba researcher, Song Liu, created a potent biocide that kills all bacterial cells – even the antibiotic-resistant ones. The biocide was limited to surface wounds due to its poor selectivity between bacterial and mammalian cells, but if they could deliver the biocide to a target inside the body, it would kill even the most resistant superbug.  Accompanying Liu’s work, Ho encased the biocide in solid-lipid nanoparticles and then added an antibody – a protein that would seek out Methicillin-resistant strafill cock us are e us bacteria over other cells. When the solid-lipid nanoparticles reach the bacteria, they release the biocide, killing the target but leaving healthy cells unaffected. The optimal outcome.  The results from the initial experiments appear to be quite promising. Still, there is a lot of work to do before this is available as an alternative to antibiotics. The next step is to find out whether the biocide gets released outside or inside the cell according to the researchers.   The researchers also believe that antimicrobial resistance will be unlikely to happen with their solid-lipid nanoparticles because the antibodies that are being used to target Methicillin-resistant strafill cock us are e us won’t cause the bacteria to develop an enzyme or other defence mechanisms in response.  This therapy offers a new line of defence in this critical time to confidently outpace antibiotic resistance.  +++++  Well, that’s it for this week’s episode of Biotechnology Focus radio. Perhaps next week there will be more riveting news from these universities and more from others I am sure. Modern medicine is advancing at such a pace, it’s hard to keep up! Be sure to check our website for the full stories and get your fill daily of what's happening on the Canadian biotech scene at www.biotechnologyfocus.ca. Thanks so much for listening in! Hope you have a great week ahead. From my desk to yours – this is Michelle Currie.   

Neutrophil grabbing Staph. From Wikipedia No, your eyes aren't deceiving you, and yes, we know how to count... Episode 29 is still in limbo as Camilla valiantly attempts to re-record just her portion. In this episode, Kevin and Camilla discuss Salmonella virulence, and how different strains alter the immunogenicity of pathogens. Oh, and Kate's here too... KATE'S BACK!! WOO!! Dr. Franz has a new job, but is just as snarky and ill-prepared as ever. Plus she refuses to drink on the job.Donate to us on Patreon!Like us on Facebook!And don't forget to share us with your friends so we can grow!EDIT: Sorry if this showed up in your feed late - there was a mistake in formatting :-(LinksThe Paper: Strains of bacterial species induce a greatly varied acute adaptive immune response: the contribution of the accessory genomeShort Path DistilleryOrgan Preservation Alliance (where Kate works now)

Hosts: Ed Brown, Dr. Shyane Joseph, Penny Dumsday. 00:01:08 A 7-year-old boy's life is saved from a rare skin disease after researchers genetically modify and grow his skin in a lab. 00:07:25 The widespread use of penicillin may been a factor in the very early development of Methicillin-resistant Staphylococcus aureus (MRSA). 00:15:06 A new study suggests that while cold blooded dinosaurs ruled the daytime, mammals evolved to be nocturnal. And when the dinosaurs were wiped out, many mammals switched back to diurnal life. 00:19:21 NASA scientists say the giant hole in the ozone layer is shrinking, and is now the smallest it's ever been since 1988. 00:24:15 Eleven papers have been published in the journal Clinical Infectious Diseases and presented at the recent scientific meeting revealing the scale and damage caused by streptococcus infections. The authors have called for an acceleration in the development of a streptococcus vaccine.   This episode contains traces of protestors crashing a side event at the 23rd Conference of Parties to the United Nations Framework Convention on Climate Change, known as COP 23. The US sent only a small delegation of low-level Whitehouse staffers and representatives from fossil fuel and nuclear power organisations to speak on a panel. Former New York City mayor Mike Bloomberg observed that “promoting coal at a climate summit is like promoting tobacco at a cancer summit.”  

Methicillin resistant Staphylococcus aureus, or MRSA is a bacteria that is resistant to many common antibiotics. It can cause a variety of problems ranging from are skin infections and sepsis to pneumonia to bloodstream infections. Monday is World MRSA Day, a day to raise the awareness of MRSA around the globe and to activate survivors, communities, governments, healthcare officials and personnel to join together to stop the spread of this preventable disease. Founder of MRSA Survivors Network , Jeanine Thomas joined me to discuss MRSA, World MRSA Day and to tell her personal story as a MRSA survivor.

Methicillin resistant Staphylococcus aureus, or MRSA is a bacteria that is resistant to many common antibiotics. It can cause a variety of problems ranging from are skin infections and sepsis to pneumonia to bloodstream infections. Monday is World MRSA Day, a day to raise the awareness of MRSA around the globe and to activate survivors, […] The post A conversation with MRSA Survivors Network founder, Jeanine Thomas appeared first on Outbreak News Today.

What happens when you're one of the first cases of Methicillin-resistant Staphylococcus aureus in your home town? A whole bunch of f**kery that's what!   This week on Sickboy we sit down with Jess and talk about her experience in dealing with a nasty case of "Super Bug"! We talk about everything from the weird names children call vagina, the horrendous origin story of a flesh eating bacteria, disgustingly horrendous visions of lancing boils on youtube, endless sexual innuendo's and much much more. Oh and of course, Happy Birthday Wanda!   ***We need your help! We’re just on the cusp of securing some sponsors! Help us turn this from a labour of love to a labour of being paid like a real grown up. Take 2 minutes of your day to fill out a SUPER simple survey over at: Survey.libsyn.com/Sickboy***   As always this wouldn't be possible if it wasn't for our amazing listeners. We rely on you to keep this project going! If you'd like to add to that please consider supporting us on Patreon https://www.patreon.com/sickboy   Theme music provided by the babes over at Take Part. If you dig it check them out on Bandcamp!   Shout out to @Sp00nfed for the post work   Like us on Facebook https://www.facebook.com/sickboypodcast Follow us on Instagram https://www.instagram.com/sickboypodcast/ Make love to us on Twitter https://www.twitter.com/sickboypodcast

What happens when you're one of the first cases of Methicillin-resistant Staphylococcus aureus in your home town? A whole bunch of f**kery that's what! This week on Sickboy we sit down with Jess and talk about her experience in dealing with a nasty case of ""Super Bug""! We talk about everything from the weird names children call vagina, the horrendous origin story of a flesh eating bacteria, disgustingly horrendous visions of lancing boils on youtube, endless sexual innuendo's and much much more. Oh and of course, Happy Birthday Wanda!"

What happens when you're one of the first cases of Methicillin-resistant Staphylococcus aureus in your home town? A whole bunch of f**kery that's what! This week on Sickboy we sit down with Jess and talk about her experience in dealing with a nasty case of ""Super Bug""! We talk about everything from the weird names children call vagina, the horrendous origin story of a flesh eating bacteria, disgustingly horrendous visions of lancing boils on youtube, endless sexual innuendo's and much much more. Oh and of course, Happy Birthday Wanda!"

New #Science says that 7 out of 10 people have a bacteria in their noses which can kill the unkillable #MRSA, or Methicillin-resistant #Staphylococcus aureus! Fook sees this as good news since he admittedly loves to #pick his #nose. Staphylococcus lugdunensis is the superhero here, which can produce #lugdunin, an antibiotic researchers hope to harness and use on our keyboards and cell phones. So, next time you have a cut, put a #booger on it? #altlakecity

Natasha Trenev, who is known as The Mother of Probiotics, joins Mark Alyn to talk about, you guessed it–Probiotics! Probiotics means for life, where Antibiotics means against life. Over 100 trillion Probiotic microbes are in our gut and they control your health. Live Yogurt has probiotics, these do not include the sugary yogurts you find in the local grocery store. The problem with these sugary yogurts is that they feed the bad bacteria in your gut. Why should you take a Probiotic? Natasha explains how the environment has changed over the last 40 year. These changes have introduced multiple new microbes that have become resistant in our communities. These include MRSA or Methicillin-resistant Staphylococcus aureus (MRSA) a bacterium responsible for several difficult to treat infections in humans. It is also called oxacillin-resistant Staphylococcus aureus (ORSA). MRSA is any strain of Staphylococcus aureus that has developed, through the process of natural selection, resistance to beta-lactam antibiotics, which includes the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. These strains are unable to resist these antibiotics and are classified as methicillin-sensitive; Staphylococcus aureus, or MSSA. The evolution of such resistant bacteria does not cause the organism to be more intrinsically virulent than strains of S. aureus that have no antibiotic resistance, but resistance does make MRSA infection more difficult to treat with standard types of antibiotics and thus more dangerous. Natasha talks about the benefits of Kombucha. Kombucha is a tea-based, fermented drink beverage that is often taken for its health benefits or medicinal purposes. Kombucha is a living organism drink made by fermenting tea and with the Kombucha culture. The result can taste like something between sparkling apple cider and champagne, depending on what flavor tea you use. The first recorded use of kombucha comes from China in 221 BC during the Tsin Dynasty. It was known as “The Tea of Immortality”. One of the benefits of Kombucha is that it helps the body absorb vitamins and minerals.

Natasha Trenev, who is known as The Mother of Probiotics, joins Mark Alyn to talk about, you guessed it–Probiotics! Probiotics means for life, where Antibiotics means against life. Over 100 trillion Probiotic microbes are in our gut and they control your health. Live Yogurt has probiotics, these do not include the sugary yogurts you find in the local grocery store. The problem with these sugary yogurts is that they feed the bad bacteria in your gut.Why should you take a Probiotic? Natasha explains how the environment has changed over the last 40 year. These changes have introduced multiple new microbes that have become resistant in our communities. These include MRSA or Methicillin-resistant Staphylococcus aureus (MRSA) a bacterium responsible for several difficult to treat infections in humans. It is also called oxacillin-resistant Staphylococcus aureus (ORSA). MRSA is any strain of Staphylococcus aureus that has developed, through the process of natural selection, resistance to beta-lactam antibiotics, which includes the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. These strains are unable to resist these antibiotics and are classified as methicillin-sensitive; Staphylococcus aureus, or MSSA. The evolution of such resistant bacteria does not cause the organism to be more intrinsically virulent than strains of S. aureus that have no antibiotic resistance, but resistance does make MRSA infection more difficult to treat with standard types of antibiotics and thus more dangerous.Natasha talks about the benefits of Kombucha. Kombucha is a tea-based, fermented drink beverage that is often taken for its health benefits or medicinal purposes. Kombucha is a living organism drink made by fermenting tea and with the Kombucha culture. The result can taste like something between sparkling apple cider and champagne, depending on what flavor tea you use. The first recorded use of kombucha comes from China in 221 BC during the Tsin Dynasty. It was known as “The Tea of Immortality”. One of the benefits of Kombucha is that it helps the body absorb vitamins and minerals.

Natasha Trenev, who is known as The Mother of Probiotics, joins Mark Alyn to talk about, you guessed it–Probiotics! Probiotics means for life, where Antibiotics means against life. Over 100 trillion Probiotic microbes are in our gut and they control your health. Live Yogurt has probiotics, these do not include the sugary yogurts you find in the local grocery store. The problem with these sugary yogurts is that they feed the bad bacteria in your gut. Why should you take a Probiotic? Natasha explains how the environment has changed over the last 40 year. These changes have introduced multiple new microbes that have become resistant in our communities. These include MRSA or Methicillin-resistant Staphylococcus aureus (MRSA) a bacterium responsible for several difficult to treat infections in humans. It is also called oxacillin-resistant Staphylococcus aureus (ORSA). MRSA is any strain of Staphylococcus aureus that has developed, through the process of natural selection, resistance to beta-lactam antibiotics, which includes the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. These strains are unable to resist these antibiotics and are classified as methicillin-sensitive; Staphylococcus aureus, or MSSA. The evolution of such resistant bacteria does not cause the organism to be more intrinsically virulent than strains of S. aureus that have no antibiotic resistance, but resistance does make MRSA infection more difficult to treat with standard types of antibiotics and thus more dangerous. Natasha talks about the benefits of Kombucha. Kombucha is a tea-based, fermented drink beverage that is often taken for its health benefits or medicinal purposes. Kombucha is a living organism drink made by fermenting tea and with the Kombucha culture. The result can taste like something between sparkling apple cider and champagne, depending on what flavor tea you use. The first recorded use of kombucha comes from China in 221 BC during the Tsin Dynasty. It was known as “The Tea of Immortality”. One of the benefits of Kombucha is that it helps the body absorb vitamins and minerals.

Natasha Trenev, who is known as The Mother of Probiotics, joins Mark Alyn to talk about, you guessed it–Probiotics! Probiotics means for life, where Antibiotics means against life. Over 100 trillion Probiotic microbes are in our gut and they control your health. Live Yogurt has probiotics, these do not include the sugary yogurts you find in the local grocery store. The problem with these sugary yogurts is that they feed the bad bacteria in your gut.Why should you take a Probiotic? Natasha explains how the environment has changed over the last 40 year. These changes have introduced multiple new microbes that have become resistant in our communities. These include MRSA or Methicillin-resistant Staphylococcus aureus (MRSA) a bacterium responsible for several difficult to treat infections in humans. It is also called oxacillin-resistant Staphylococcus aureus (ORSA). MRSA is any strain of Staphylococcus aureus that has developed, through the process of natural selection, resistance to beta-lactam antibiotics, which includes the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. These strains are unable to resist these antibiotics and are classified as methicillin-sensitive; Staphylococcus aureus, or MSSA. The evolution of such resistant bacteria does not cause the organism to be more intrinsically virulent than strains of S. aureus that have no antibiotic resistance, but resistance does make MRSA infection more difficult to treat with standard types of antibiotics and thus more dangerous.Natasha talks about the benefits of Kombucha. Kombucha is a tea-based, fermented drink beverage that is often taken for its health benefits or medicinal purposes. Kombucha is a living organism drink made by fermenting tea and with the Kombucha culture. The result can taste like something between sparkling apple cider and champagne, depending on what flavor tea you use. The first recorded use of kombucha comes from China in 221 BC during the Tsin Dynasty. It was known as “The Tea of Immortality”. One of the benefits of Kombucha is that it helps the body absorb vitamins and minerals.

Dr Sheldon Kaplan (from Texas Children’s Hospital) and Dr Bill Barson joins Dr Mike in the PediaCast Studio to talk about Methicillin-resistant Staphylococcus aureus (MRSA). We discuss the emergence of this pathogen, typical disease symptoms, diagnosis and treatment strategies in light of antibiotic resistance. We also cover recurrent MRSA infections and ways to prevent them. We hope you can join us!

How To Pick A Pet Food Lucy Pet Foundation's Doc Halligan has what you need to know in order to pick the best food for your pet and your budget. Just because it's expensive doesn't mean it's good. You'll learn how to read the label. Things Your Vet Wished You Worried About More Animal Radio Veterinary Correspondent Dr. Marty Becker has a list of things he wishes his clients would pay more attention to than they do. He'll also tell you what you unnecessarily worry too much about. Pets Destroy Eight Million Electronic Devices A new study says American pets have bitten, chewed or damaged at least 8-million electronic devices! All that damage caused an estimated $3 billion in repair and replacement costs! Researchers found 1/3rd of the damaged devices were smart-phones; 2/3rds of the incidents happened when the pet was not being supervised. And interestingly, male pets are 50% more likely than female pets to damage electronic devices. Pets May Be Breeding Ground For MRSA A new study suggests family pets might actually be reservoirs for Methicillin-resistant Staphylococcus aureus, or MRSA. Researchers believe pets might be an important factor behind the increase of MRSA outbreaks. Healthiest Breeds Pet Breeds compiled a list of 33 dog breeds that either have a clean health record, or are associated with only one, two or three health problems at most. And, the top seven have NO major or minor health concerns at all. They are... Read More… Next Week: Amanda Jones - Kathy Mormino (AKA: The Chicken Chick) - Kat Smith

The holistic health profession is on the rise. Many Americans are seeking out holistic and spiritual healers as an alternative to cure their ailments without subjecting their bodies to possible side effects from prescription drugs and going under the knife on the operating table. But how do you know when it's time to seek conventional medical care vs holistic care? In the ninth episode of Better Said Than Written, Holistic Health Practitioner, Kelarius Finex, explains the benefits of holistic care and knowing when to seek medical treatment. Kelarius shares her personal story of how she recently incorporated holistic and spiritual healing while her daughter was going through rigorous treatments for Methicillin-resistant Staphylococcus aureus, or MRSA. Kelarius' story goes a little deeper when she opens up about losing her mother to AIDS. Kelarius' mother was 59 when she died from the human immunodeficiency virus in 2014. Her mother fought to live a little while longer through spiritual healing instead of seeking medical treatment while she was living with HIV, which eventually took her life after it transformed into AIDS.

Methicillin-resistant Staphylococcus aureus (MSRA) has become a global public health problem. In a world where antibiotics are failing us, is there a chance to stop it?

Thu, 6 Jun 2013 12:00:00 +0100 https://edoc.ub.uni-muenchen.de/15816/ https://edoc.ub.uni-muenchen.de/15816/1/Scholhoelter_Janina_Lydia.pdf Scholhölter, Janina Lydia

Resistance and virulence mechanisms are discussed.  Clinical presentations as well as the difference between colonization and infection are considered.Screening, prevention, and understanding Community Acquired MRSA vs Healthcare Acquired MRSA strains can be challenging, so practical information is presented for the common questions patients, families, and health care workers will often have.

Methicillin-resistente Staphylococcus aureus (MRSA) sind die häufigsten multiresistenten Erreger. Sie erhöhen Morbidität und Mortalität und lassen die Kosten im Gesundheitssystem steigen. Der Prävention von Infektionen mit MRSA kommt daher große Bedeutung zu – vor allem, weil sich in den letzten Jahren Erreger mit neuen Multiresistenzen ausbreiten.

Methicillin-resistente Staphylococcus aureus (MRSA) sind die häufigsten multiresistenten Erreger. Sie erhöhen Morbidität und Mortalität und lassen die Kosten im Gesundheitssystem steigen. Der Prävention von Infektionen mit MRSA kommt daher große Bedeutung zu – vor allem, weil sich in den letzten Jahren Erreger mit neuen Multiresistenzen ausbreiten.

The possibility of Methicillin-resistant Staphylococcus Aureus (MRSA) infection is now a concern for many patients receiving hospital treatment. However, accumulating evidence shows that MRSA can also be carried by animals and then passed on to people in contact. Here Professor Katharina Staerk and colleagues describe their research to identify novel methods of preventing MRSA infection and transmission as part of an EU consortium.

MRSA, otherwise known as Methicillin-resistant Staphylococcus aureus, may be the greatest public health threat since AIDS. What is being done to combat this deadly disease? On this program, Maryn McKenna discussed the threat of this Superbug.

Guest: Paul Drinka, MD, CMD Host: Eric Tangalos, MD Multi-drug resistant organisms (MRDOs), such as Methicillin-resistant Staphylococcus aureus (MRSA), due to antibiotic use are of significant concern. Not only hospitals, but also long-term care facilities, are particularly susceptible to the impact of antibiotic resistance. Dr. Paul Drinka, clinical professor of internal medicine and geriatrics at University of Wisconsin-Madison and the Medical College of Wisconsin-Milwaukee, tells us that one evidence-based approach is to maintain a database of the MRDOs that will help identify clustering of a specific isolate and document a facility's resistance problem, which can then be addressed more precisely. What other specific steps might facilities take to prevent unnecessary use of antibiotics and therefore limit resistance? Dr. Eric Tangalos hosts.

Sat, 13 Feb 2010 12:00:00 +0100 https://edoc.ub.uni-muenchen.de/11531/ https://edoc.ub.uni-muenchen.de/11531/1/Frick_Johannes.pdf Frick, Johannes ddc:590, ddc:

Jeff Bender is a professor of veterinary public health at the University of Minnesota, and his research interests lie in the intersection of animal health and human health, including animal-borne diseases of humans, food safety, and antibiotic resistant pathogens in animals.  Dr. Bender will speak on “Methicillin-resistant Staphylococcus aureus ( MRSA) in Veterinary Practice” at the American Society for Microbiology’s General Meeting in Philadelphia this May. To a microorganism, vertebrates can all look pretty similar.  Dr. Bender’s work focuses on pathogens that can make themselves at home in both human bodies and the bodies of our pets and livestock.  Outbreaks of bacterial illnesses from meat products are well publicized these days, but the pathogens we have in common with animals don’t just travel in one direction.  We humans can pass organisms and diseases to our animals, too.  Dr. Bender says pets treated at veterinary clinics, for example, have come down with painful MRSA skin infections they picked up from their owners.  Fluffy might become a temporary reservoir of MRSA in your home – capable of reinfecting you and your family, but the good news is that she probably won’t be a long term carrier of the bacterium. In this interview, Dr. Merry Buckley asks Dr. Bender about MRSA in pets, whether farmers often get sick from animal-borne diseases, and whether he thinks it’s a good idea to “go organic” when shopping for food.

Methicillin-resistant Staphylococcus aureus (MRSA)